TrialJAMA oncology2020

Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer: An Analysis of the Ongoing Phase 2 Adaptively Randomized I-SPY2 Trial.

Rita Nanda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.